Phage display libraries have provided an extraordinarily versatile technology to facilitate the isolation of peptides, growth factors, single chain antibodies, and enzymes with desired binding specificities or enzymatic activities. The overall diversity of peptides in phage display libraries can be significantly limited by Escherichia coli protein folding and processing machinery, which result in sequence censorship. To achieve an optimal diversity of displayed eukaryotic peptides, the library should be produced in the endoplasmic reticulum of eukaryotic cells using a eukaryotic display platform. In the accompanying article, we presented experiments that demonstrate that polypeptides of various sizes could be efficiently displayed on the envelope glycoproteins of a eukaryotic virus, avian leukosis virus (ALV), and the displayed polypeptides could efficiently attach to cognate receptors without interfering with viral attachment and entry into susceptible cells. In this study, methods were developed to construct a model library of randomized eight amino acid peptides using the ALV eukaryotic display platform and screen the library for specific epitopes using immobilized antibodies. A virus library with approximately 2 ϫ 10 6 different members was generated from a plasmid library of approximately 5 ϫ 10 6 diversity. The sequences of the randomized 24 nucleotide/eight amino acid regions of representatives of the plasmid and virus libraries were analyzed. No significant sequence censorship was observed in producing the virus display library from the plasmid library. Different populations of peptide epitopes were selected from the virus library when different monoclonal antibodies were used as the target. The results of these two studies clearly demonstrate the potential of ALV as a eukaryotic platform for the display and selection of eukaryotic polypeptides libraries.
Introduction
Phage display technology, the display of libraries of modularly coded polypeptides on filamentous bacteriophage and screening them for specific properties, has provided a versatile technology for the discovery and characterization of protein-protein interactions (see reviews Bradbury, 1999 Bradbury, , 2000 Li, 2000) . Phage display libraries have been used to select polypeptides that specifically bind to unique antigens on immobilized proteins and to targeted receptors on cul-tured cells (Li, 2000) . More recently, several groups have developed in vivo selection strategies of phage display polypeptide libraries in mice (Johns et al., 2000; Pasqualini and Ruoslahti, 1996; Rajotte et al., 1998; Rajotte and Ruoslahti, 1999) . These selection strategies enable the study of cells, organs, and tumors in their natural environment, a complexity that is difficult to model in cultured cells. Several peptides with specific binding properties identified by phage display technology have been used to target therapeutic drugs to tumors Ellerby et al., 1999) and/or to alter the biodistribution of adenoviral gene therapy vectors (Trepel et al., 2000) .
While phage display technology has many advantages, it also has limitations. The limitations of phage display are Fig. 1 . Schematic representations of the construction and screening of the ALV 8-mer peptide display library. Construction: The plasmid encoding the FXL(A) ALV virus was used to construct the plasmid library. The FXL(A) virus was constructed from the RCASBP(A)AP infectious molecular clone containing the gag, pol, and env viral genes, and a heat-stable alkaline phosphatase (AP) reporter gene flanked by viral long-terminal repeats (LTRs). The FXL(A) env gene encodes five nonviral epitopes in-frame at the N-terminus of SU: the eight amino acid FLAG epitope tag, the SfiI and NotI restriction enzyme sites, the Factor Xa (Fxa) protease cleavage site, and a flexible linker consisting of glycine, glycine, glycine, glycine, and serine (G 4 S). The 24 nucleotides (N 24 ) encoding the FLAG epitope in FXL(A) env were randomized by PCR; the amplified PCR fragments were subcloned into the unique mainly related to the restrictions imparted by Escherichia coli on the expression, assembly, folding, transport, and posttranslational modifications of the viral proteins and their incorporation into viral particles (Jestin et al., 2001; Smith and Petrenko, 1997; Wilson and Finlay, 1998) . The host biology restrictions result in a significant reduction in the synthesis of viral proteins fused to nonviral polypeptides due to differences in codon usage, a high frequency of partial proteolysis and/or misfolding of the fusion protein, and defects in the transport and/or incorporation of the fusion proteins into viral particles. These restrictions can significantly reduce the sequence diversity of the polypeptides actually displayed on viruses in a phage display library (Rodi et al., 2002) . In addition, bacteria do not have the enzymatic machinery to posttranslationally modify proteins (e.g., N-linked glycosylation), a characteristic of many eukaryotic proteins that can be important for folding, assembly, solubility, and binding interactions. The development of a viral polypeptide display platform capable of efficient synthesis of eukaryotic polypeptides in eukaryotic cells and display of the polypeptides on virions would expand the versatility of display technology.
Retroviruses have characteristics that make them promising candidates to be a eukaryotic platform for the display of eukaryotic polypeptides. Eukaryotic cells also have an efficient quality control system that assesses whether a protein has been properly folded and modified, including retroviral glycoproteins, before transport to the cell surface and incorporation into virions (reviewed in Braakman and van Anken, 2000; Chevet et al., 2001) . The display of a variety of nonviral polypeptides on the SU glycoprotein of a murine retrovirus, murine leukemia virus (MLV), demonstrated that a library of polypeptides could be display on a retrovirus, and the library selected against eukaryotic cellular targets (reviewed in Russell and Cosset, 1999) . Since these initial studies, characteristics that limit the usefulness of MLV as a display platform have been found. The displayed polypeptides were found to be shed from MLV virions at a significant rate; certain displayed polypeptides could block MLV infection of susceptible cells, and the infectivity of MLV displaying SU-polypeptide fusions were significantly reduced compared to wild-type virus (Ager et al., 1996; Cosset et al., 1995; Nilson et al., 1996) .
The characteristics of another retrovirus, the avian leukosis virus (ALV), appeared to offer advantages over MLV as a eukaryotic platform for the display of eukaryotic polypeptides as SU fusion proteins. The displayed polypeptides will be maintained on ALV virions since little or no SU is normally shed from ALV due to a covalent bond between the SU and TM glycoproteins (Einfeld and Hunter, 1988) . The ALV genome can also stably maintain up to 2.5 kb of additional sequence, providing ample room to encode SU fusions displaying large nonviral polypeptides, and still encode a replication-competent virus (Federspiel and Hughes, 1997) . In the accompanying study, we demonstrated that polypeptides of various sizes could be efficiently displayed as N-terminal SU fusions on ALV virions, and the displayed polypeptide could efficiently attach to a cognate receptor immobilized on a solid support or expressed on the cell surface. The foreign polypeptides did not interfere with the attachment and entry functions of the underlying ALV envelope glycoproteins in virions, and the genes encoding the chimeric glycoproteins were stably maintained through multiple virus replication cycles. In this study, we tested whether we could develop methods to construct a model library of randomized peptides displayed on ALV, and screen the library for specific epitopes using immobilized antibodies.
Results and discussion

Virus enrichment was specific upon selection of a displayed epitope with an immobilized antibody
The process of screening a peptide display library to select rare peptides that bind a target depends on an efficient selection protocol (Fig. 1 ). The protocol for screening an ALV peptide display library was developed and optimized by testing different selection conditions on the efficiency of recovering a virus displaying a known peptide at different concentrations (1-50% of the virus population) by an immobilized antibody. Different ratios of the ALV-GFP virus with no displayed peptide and the FXL(A) virus displaying the FLAG tag peptide (DYKDDDDK) were selected in a tissue culture dish coated with an immobilized anti-FLAG monoclonal antibody. Bound viruses were recovered by adding DF-1 cells to allow virus infection and amplification. The optimal selection conditions produced a consistent Ͼ100-fold enrichment for the FXL(A) Flag displaying tar-KpnI-NotI sites of FXL(A), and the resulting plasmids were transformed into E. coli to produce the 8-mer plasmid library (each different eight amino acid peptide is represented by a different colored square). ALVs displaying the chimeric envelope glycoproteins were produced by transfecting plasmid library DNA containing the infectious molecular clones into chicken DF-1 cells (the different 8-mer peptides are represented as colored circles; the two strands of viral genomic RNA are represented by colored rectangles). Since the DNA transfection procedure results in the entry of multiple plasmids into a cell, and each plasmid encodes a different peptide, each transfected cell will express many different chimeric glycoproteins that can be incorporated into viral particles that will not be encoded by the encapsidated viral genomic RNA. Therefore, the initial production of recombinant viruses results in an Unlinked Virus Library, i.e., the chimeric glycoproteins expressed on the virion surface are not encoded by the viral RNA. Fresh DF-1 cells were infected with the Unlinked Virus Library at a low multiplicity of infection (m.o.i.) to link the displayed glycoprotein phenotype with the packaged genotype in each virus of the Virus Library. Selection: A target antibody (Y) is coated onto a solid support, treated to reduce nonspecific virus binding, and incubated with the ALV peptide display library. After washing to remove unbound viruses, DF-1 chicken cells are added to amplify the bound viruses. The selection strategy can be repeated to select dominant peptides that bind a protein target. get virus (Table 1) , a level and specificity of enrichment that should allow the selection of rare binding peptides after several rounds of screening.
Overview of the experimental approach for constructing an ALV peptide display library
In the accompanying article, we demonstrated that biologically active polypeptides of different sizes could be efficiently displayed on ALV virions as N-terminal extensions of the SU glycoprotein without altering ALV entry and replication. To test whether ALV could be a platform for the display of a library of random peptides that are linked to the viral genotype, a model ALV peptide display library was constructed based on the ALV virus displaying the FLAG epitope, FXL(A) (see accompanying article). The organization of the nonviral epitopes fused to the N-terminus of the FXL(A) SU glycoprotein and the major steps of the ALV 8-mer peptide display library construction are shown in Fig. 1 .
Construction of the randomized plasmid library
The 24 nucleotides that encode the eight amino acid FLAG epitope of FXL(A) plasmid were randomized by synthesizing overlapping primers comprising random nucleotides in this region flanked by fixed nucleotide sequences. This pool of 3Ј-primers was used with a fixed 5Ј-primer to amplify the viral region encoding the signal peptide of the N-terminus of env by PCR. The amplified fragments were digested with KpnI and NotI and inserted into the F␣CXL(A) plasmid containing the infectious molecular clone. The ligated plasmids were transformed into bacteria and grown under drug selection to amplify the plasmid library. Since the plasmids containing the ALV molecular clones do not transcribe or translate the ALV sequences in bacteria, we do not expect the maintenance of certain plasmids to be under selective pressure and result in a bias of the library. Therefore, the sequence diversity of the targeted 24-nucleotide region of the plasmids should be random in the plasmid library.
A summary of the construction parameters of the randomized plasmid library is shown in Table 2 . The maximum possible sequence diversity of the plasmid library is the number of transformed bacterial colonies harvested, 5 ϫ 10 6 . The nucleotide sequences of the plasmids contained in 176 individual colonies were determined to analyze the actual sequence diversity of the 24-nucleotide randomized region, and the diversity of the translated peptides, obtained in the plasmid library. We estimate that the observed frequency of each nucleotide in the randomized region of the plasmid library reflects the synthesized primers used to amplify the region. Using the observed sequences, several sets of statistical analyses were used to test whether there was any correlation of nucleotide with position in the 24mer sequence and whether there was any clustering of certain combinations of nucleotides. These analyses suggest a nonrandom mechanism such that the nucleotide selection probabilities vary with position in the randomized sequence, although there was no obvious pattern (data not shown). While the process was not strictly random, the statistical analyses did demonstrate great diversity in the pool of plasmid sequences.
Construction of the ALV 8-mer randomized peptide display library
ALV replication can be initiated by the transfection of chicken DF-1 cells with plasmid DNA containing an infectious molecular clone in a proviral form (Federspiel and Hughes, 1997) . To produce an ALV peptide display library, the randomized plasmid library was transfected into DF-1 cells to produce infectious virus. However, the transfection procedure often results in multiple plasmids entering each transfected cell, and in this case each plasmid encodes a viral glycoprotein that displays a different peptide. Therefore, each transfected cell will contain many different viral genomes and express multiple viral glycoproteins displaying different peptides on the cell surface. Since each infectious ALV produced by these cells will have a variety of glycoproteins displaying different peptides and two copies of the viral genome that may not encode any of the displayed peptides, the displayed peptide phenotype is not linked to the viral genotype. To link the phenotype with the genotype in each virus, fresh DF-1 cells were infected with a low level [0.1 multiplicity of infection (m.o.i)] of this A) with a wild-type envelope glycoprotein and containing the GFP reporter gene (wt-GFP) was mixed with different amounts of FXL(A), the RCASBP(A) virus displaying the Flag epitope on the envelope glycoproteins and containing the AP reporter gene (Flag-AP). The virus mixture was incubated in wells coated with an anti-Flag mAb and washed, and the bound virus amplified by adding DF-1 cells. b The titers of the input and recovered wt-GFP virus were determined by FACS.
c The titers of the input and recovered Flag-AP virus were determined by AP assay.
d Determined by dividing the recovered/input ratios of Flag-AP with wt-GFP. e The wt/Flag virus ratio of 1:1 selected and amplified as above but without the immobilized anti-Flag mAb.
initial unlinked ALV peptide display library so that each cell would be infected by only one virus. The subsequent "deconvoluted" virus pool was amplified to produce the now linked ALV 8-mer peptide display library. A summary of the construction parameters of the model ALV 8-mer peptide display library is shown in Table 2 .
No evidence of sequence censorship was detected from converting the plasmid library of ALV molecular clones to a virus display library
One goal of these experiments was to determine if a significant sequence censorship of the possible randomized sequences would occur upon producing an ALV virus peptide display library from the randomized plasmid library. The generation of the ALV 8-mer peptide display library resulted in some loss of sequence diversity of the randomized 24-nucleotide region from the randomized plasmid library. Minimally, viral genomes that contain nonviral sequences that encode a termination codon are lost since functional glycoproteins cannot be synthesized, resulting in the production of noninfectious virus. Other nonviral peptides that reduce the efficiency of glycoprotein processing and/or transport might also be lost, resulting in a further reduction in the actual diversity of the peptides displayed on ALV in the virus library. At each step of the generation of the virus display library, sufficient plasmid library DNA, DF-1 cells, and/or viruses from the unlinked virus library were used to maintain the maximum possible diversity that could be provided by the plasmid library. In addition, the unlinked virus library and the final linked virus library were not amplified by multiple virus passages to minimize the loss of peptide sequences that may slow viral replication.
To determine if significant sequence censorship had occurred, the nucleotide sequences of the randomized regions from 54 individual viral clones produced by RT-PCR amplification of ALV genomic RNA were determined and compared to the nucleotide sequences from the plasmid library. The overall nucleotide frequencies in the randomized sequences of the virus library were not significantly different from the frequencies observed in the plasmid library (Table 2 ). In addition, the relative frequency of each amino acid at each position in the 8-mer peptides encoded by the plasmid library is statistically similar to the virus library except for the frequency of the termination codons, which were greatly reduced in the virus library (Fig. 2) . We conclude from these analyses that the overall sequence diversity of the randomized region of the plasmid peptide display library was maintained in the virus library without detectable bias.
Different populations of peptides were selected from the ALV 8-mer peptide display library with different target antibodies
The optimal conditions for screening ALV were determined using a mixture of wild-type ALV and ALV displaying one type of peptide, FLAG (Table 1) . These screening conditions were then tested to determine if a particular ALV displaying FLAG peptide, FXL(A), could be efficiently selected from a complex mixture of peptide displaying viruses, the ALV 8-mer library. An aliquot of the ALV 8-mer library was spiked with ϳ1% FXL(A) virus and selected with the anti-FLAG monoclonal antibody for three rounds. Viral genomes from each selected population were amplified by RT-PCR and cloned, and the nucleotide sequence of 10 -20 clones were determined. The majority of the viruses recovered after each round of selection coded for the expected FLAG peptide from FXL(A), DYKDDDDK (Fig.  3A) . However, despite the high concentration of the spiked FXL(A) virus, other peptides homologous to the optimal FLAG peptide were also selected, e.g., DYQDHDHK (Round 1), DTRMTDDK (Round 2), and DYKDDDDM (Round 3).
To further test the library screening conditions, the same aliquot of the ALV 8-mer library spiked with FXL(A) was screened for peptides that bind two other monoclonal antibodies, an antiinfluenza hemaglutinnin antibody (anti-HA) that recognizes the peptide YPYDVPDYA Fig. 3B ), and an antivesicular stomatitis virus (VSV) glycoprotein antibody (anti-VSV glycoprotein) that recognizes the peptide NR-LGK (Fig. 3C) . A different dominant peptide was selected from the virus library by each immobilized target antibody after three rounds of screening, PPATYSSH by anti-HA, and NCNTPFWA by anti-VSV glycoprotein. We believe the screening was successful for both targets since it is not unusual for peptides to be specifically selected using a display technology that is different from the optimal peptide recognized by the target antibody (Ferrieres et al., 2000; Scott and Smith, 1990; Tighe et al., 1999) . These results demonstrate that the procedure for screening this ALV peptide display library with an immobilized antibody is efficient and selects peptides specific for that target.
Conclusions
In this study we demonstrate that ALV is indeed a useful eukaryotic platform for the display of a randomized peptide library of reasonable sequence diversity. We also have developed efficient screening procedures for the selection of specific peptides that bind to immobilized target proteins. We are now in the process of building a very large ALV peptide display library (ϳ10 9 sequence diversity) that will be used to isolate a variety of cell-targeting peptides.
Materials and methods
Plasmid library construction
The construction of the RCASBP(A)/AP retroviral vector, an ALV-based replication competent vector with a subgroup A env gene (A), and the heat-stable human placental alkaline phosphatase gene (AP), has been described (Federspiel and Hughes, 1997; Fekete and Cepko, 1993; Fields-Berry et al., 1992) . The plasmid FXL(A) is derived from RCASBP(A)AP and contains five nonviral regions in-frame at the N-terminus of SU (ϩ1): the 24 nucleotides FLAG epitope (DYKDDDDK), two restriction endonuclease sites SfiI and NotI, a factor Xa protease cleavage site, and a glycine-glycine-glycine-glycine-serine (G 4 S) linker. The plasmid F␣CXL(A) is derived from retroviral vector FXL(A) and contains an additional anti-carcinoembryonic antigen (CEA) single-chain antibody (scFv) between the SfiI and NotI restriction enzyme sites. The FXL(A) and F␣CXL(A) plasmids have been described in the accompanying article. For library construction, the unique KpnI-NotI restriction fragment of FXL(A) was subcloned into the KS(ϩ) plasmid (Stratagene, La Jolla, CA) at the same restriction sites. The 24-nucleotide sequence encoding the FLAG epitope was randomized by PCR: the 5Ј-PCR primer 5Ј-ATAAGGTTATTTGGGTACCCTCTCGGAAAGTTA-AACCGG AT-3Ј and a 3Ј-PCR primer pool was synthesized 5Ј-AATGGCGGCCGCGGCCGGCTGGGCC GCNNNNN-NNN NNNNNNNNNNNNNNNNAG CTCTTACCCCCG-TAA-3Ј, where N denotes all four A, T, C, and G nucleotides. The nucleotide primers were synthesized by the Mayo Clinic Molecular Biology Core using a PE Applied Biosys- Fig. 2 . The frequency of each amino acid at each position in the 8-mer peptide encoded in the plasmid library and the virus library. The nucleotide sequence was determined from representatives of the plasmid library directly (176 different colonies), and the virus library after amplification of the region by RT-PCR and subcloning (54 colonies). Tryptophan (W) was not encoded in the peptides of the sequenced representatives of the virus library (*);however, tryptophan was represented in other viruses (see Fig. 3 ). The frequency profiles of the plasmid and virus libraries do not reflect the theoretical expected amino acid frequencies due to the differential degradation of the stock nucleotides used to synthesize the randomized PCR primers. Fig. 3 . Peptides selected by different immobilized monoclonal antibodies from the ALV 8-mer peptide display library. Aliquots of the ALV 8-mer peptide display library were spiked with 1.0% FXL(A) virus and selected in plates coated with a monoclonal antibody: either against the FLAG epitope (Anti-Flag mAb), a influenza A hemaglutinnin epitope (Anti-HA mAb), or a vesicular stomatitis virus (VSV) glycoprotein epitope (Anti-VSV Glycoprotein mAb). The unbound viruses were removed by extensive washing, and the bound viruses were recovered by adding DF-1 cells to allow viral infection and amplification. The amplified pools of bound viruses were again selected as above for two more rounds. The genomic RNAs of bound virus pool from each round were amplified by RT-PCR and cloned and the nucleotide sequence was determined encoding the displayed peptide. Peptide sequences common to different rounds of selection are highlighted in different shades of gray. tems 3948 Nucleic Acid Synthesis and Purification System. The 294-bp PCR product was digested with KpnI-NotI; the digested fragment was purified (ϳ2 g) and ligated with 18 g of KpnI-NotI-digested F␣CXL(A) plasmid in a 200-l reaction containing 4 ϫ 10 4 U T4 ligase (New England Biolabs, Beverly, MA) at 16°C for 14 h. The ligation reaction was purified by phenol:chloroform extraction and ethanol precipitation and resuspended in 50 l 10 mM Tris, pH 8.0. Highly competent E. coli DH10B cells (400 l) (GIBCO/BRL) were mixed with 5 l purified ligation product for each electroporation (10 reactions total) in 0.2-cm cuvettes (Bio-Rad, Hercules, CA) pulsed with a time constant of 4.64 ms at 2.5 kV, 200 ⍀, and 25 F (Bio-Rad). Aliquots of the electroporated cells were plated onto ampicillin-containing NZY plates. Plasmid DNA was purified using Qiagen Plasmid Maxi Kits (Qiagen Inc., Valencia, CA).
Cell culture and virus propagation
DF-1 cells, a chicken fibroblast cell line (Himly et al., 1998; Schaefer-Klein et al., 1998) , were grown in Dulbecco's modified Eagle's medium (GIBCO/BRL) supplemented with 10% fetal bovine serum (GIBCO/BRL), 100 U of penicillin per ml, and 100 g of streptomycin per milliliter (Quality Biological, Inc., Gaithersburg, MD) at 39°C and 5% CO 2 . Virus propagation was initiated either by transfection of plasmid DNA that contained the retroviral vector (with wild-type or chimeric env genes) in proviral form (Federspiel and Hughes, 1997) or by direct infection. Virus stocks were generated from cell-culture supernatants. The supernatants were cleared of cellular debris by centrifugation at 2000 g for 10 min at 4°C and stored in aliquots at Ϫ80°C. Virus titers were determined by mixing 10-fold serial dilutions of the virus stock with DF-1 cells and assaying for AP activity 48 h later as described previously (Holmen et al., 1999) .
Generation of retrovirus peptide display library
To generate the ALV 8-mer virus library, 9 ϫ 10 6 DF-1 cells were transfected with 30 g plasmid DNA purified from the plasmid library using Superfect transfection reagent (Qiagen). Two days after transfection the supernatant was collected (30 ml); fresh 10% DMEM was added to cells and incubated for 12 h and the supernatant was collected and combined with day 2 (60 ml total). To deconvolute the unlinked virus library, fresh DF-1 cells (4 ϫ 10 7 ) infected with the unlinked virus library at a 0.1 m.o.i in two cell factory-2 (Nunc, Naperville, IL). The cells were split into one cell factory-10 (Nunc) when the cells were confluent (3 days) and incubated for an additional 3 days. The supernatant was collected (1000 ml), cleared, and frozen in aliquots and constitutes the ALV 8-mer peptide display library.
ALV display library selection procedure
The selection procedure was a modification of the IRISA assay published previously (Russell et al., 1993 and the accompanying article). Briefly, six-well plates (Costar, Corning, NY) were coated with anti-Flag mAb (Sigma, St. Louis, MO), anti-HA mAb (Sigma), or anti-VSV-G mAb (Sigma) (12.5 g/ml) in 2 ml/well coating buffer (0.015 M of Na 2 CO 3 ; 0.035 M of NaHCO 3 ) for 2 h at 4°C. The plates were then washed three times with PBS (2 ml/well) and nonspecific protein binding blocked with 5% bovine serum albumin for 1 h at 37°C followed by DMEM containing 10% fetal calf serum for 1 h at 37°C. Plates were washed three times with PBS and incubated with ALV virus stock (2 ml/well) for 2 h at 4°C. The plates were then washed with PBS three times followed by PBS with 0.1% Tween 80 four times. To recover and amplify the bound viruses, fresh DF-1 cells were added and the cultures were incubated for 2 days to allow virus infection and spread. The supernatants were collected, cleared, and frozen in aliquots and constituted the selected virus from that round of screening. The process was repeated for each round of selection. Virus titers were quantitated by AP assay.
Nucleotide sequence analysis
Plasmid DNA was isolated from individual colonies from the ALV 8-mer plasmid library using Qiagen Plasmid Mini Kit to determine the nucleotide sequence. Viral RNA was isolated from the aliquots of ALV 8-mer peptide display virus library using RNA Isolation Kit (Qiagen). RT-PCR was performed using a Titan one tube RT-PCR kit (Roche, Indianapolis, IN) using forward primer Env Seq. 1 5Ј-GGTCTGGGGACGAGGTT ATGC-3Ј [complementary to nucleotides 8460 -8480 of the RCASBP(A) molecular clone] and Reverse-X primer 5Ј-CCGTTTGGCCTGTACG-GTTGG-3Ј [complementary to nucleotides 8814 -8834 of RCASBP(A)]. The RT-PCR product (449 bp) was cloned into TA-cloning vector (Invitrogen Carlsbad, CA); plasmid DNA was isolated as above and the nucleotide sequence was determined. Nucleotide sequences were determined by the Mayo Clinic Molecular Biology Core on a Perkin-Elmer ABI PRISM 377 DNA sequencer (with XL upgrade) with PE Applied Biosystems ABI PRISM dRhodamine Terminator Cycle Sequencing Ready Reaction Kit and Ampli-Taq DNA Polymerase (PE Applied Biosystems, Foster City, CA).
Statistical analysis
Four major sets of statistical analyses were performed to determine if the displayed plasmid sequences behaved as if generated from a random stochastic process in which successive nucleotides are selected randomly and independently. The analyses were (1a) a comparison of the overall observed distribution of amino acids to the expected distri-bution using a 2 test on 20 degrees of freedom; (1b) a comparison of the overall observed distribution of codons to the expected distribution using a 2 test on 63 degrees of freedom; (2) an analysis of independence of nucleotide and position using 2 test on 69 degrees of freedom for a 24 ϫ 4 table; (3) an analysis of serial correlation at a lag of 1 using logistic regression with lagged variables; and (4) an analysis of clustering of nucleotides within sequence using alternating logistic regression in PROC GENMOD in SAS. These analyses were performed both for the plasmid sequences and for the virus data.
